Antibodies, Anti-Idiotypic
"Antibodies, Anti-Idiotypic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies.
| Descriptor ID |
D000888
|
| MeSH Number(s) |
D12.776.124.486.485.114.071 D12.776.124.790.651.114.071 D12.776.377.715.548.114.071
|
| Concept/Terms |
Antibodies, Anti-Idiotypic- Antibodies, Anti-Idiotypic
- Anti-Idiotypic Antibodies
- Antibodies, Anti Idiotypic
- Anti-Idiotype Antibodies
- Anti Idiotype Antibodies
- Antibodies, Anti-Idiotype
Anti-Antibodies- Anti-Antibodies
- Antiglobulins
- Antigamma Globulin Antibodies
- Antibodies, Antigamma Globulin
- Globulin Antibodies, Antigamma
- Anti Antibodies
- Antibodies, Anti
- Anti-gamma Globulin Antibodies
- Anti gamma Globulin Antibodies
- Antibodies, Anti-gamma Globulin
- Globulin Antibodies, Anti-gamma
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Anti-Idiotypic".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Anti-Idiotypic".
This graph shows the total number of publications written about "Antibodies, Anti-Idiotypic" by people in this website by year, and whether "Antibodies, Anti-Idiotypic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2002 | 0 | 2 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 2 | 2 |
| 2010 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 2 | 3 |
| 2017 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antibodies, Anti-Idiotypic" by people in Profiles.
-
RLIP depletion induces apoptosis associated with inhibition of JAK2/STAT3 signaling in melanoma cells. Carcinogenesis. 2021 05 28; 42(5):742-752.
-
Monoclonal Antibodies for the Treatment of Nasal Polyps. Immunol Allergy Clin North Am. 2017 05; 37(2):357-367.
-
Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases. Stem Cells. 2015 Oct; 33(10):2985-94.
-
High-Resolution Mapping of N6-Methyladenosine in Transcriptome and Genome Using a Photo-Crosslinking-Assisted Strategy. Methods Enzymol. 2015; 560:161-85.
-
Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. Hum Mol Genet. 2015 Aug 01; 24(15):4284-95.
-
Clinicopathologic findings in (anti-FcepsilonR1alpha) autoimmune-related chronic urticaria. J Cutan Pathol. 2015 May; 42(5):329-32.
-
Chronic idiopathic urticaria: treatment with omalizumab. Skin Therapy Lett. 2014 Nov-Dec; 19(6):1-4.
-
Should clinicians use omalizumab for the treatment of nasal polyps? J Allergy Clin Immunol. 2013 Jul; 132(1):247.
-
Successful treatment of bullous pemphigoid with omalizumab. Arch Dermatol. 2012 Nov; 148(11):1241-3.
-
A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology. 2010 09; 48(3):318-24.